​

Quest Diagnostics (DGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DGX Stock Forecast

Quest Diagnostics (DGX) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $173.83, with a high of $185.00 and a low of $165.00. This represents a 11.83% increase from the last price of $155.44.

$120 $133 $146 $159 $172 $185 High: $185 Avg: $173.83 Low: $165 Last Closed Price: $155.44

DGX Stock Rating

Quest Diagnostics stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 1 Strong Buy (8.33%), 5 Buy (41.67%), 5 Hold (41.67%), 1 Sell (8.33%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 1 5 5 1 Strong Sell Sell Hold Buy Strong Buy

DGX Forecast vs Benchmarks

TypeNameUpside
StockQuest Diagnostics11.83%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts--11
Avg Price Target--$164.91
Last Closing Price$155.44$155.44$155.44
Upside/Downside--6.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25199--19
Dec, 241810--19
Nov, 2418141-24
Oct, 2457141-27
Sep, 2456141-26
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Patrick DonnellyCitigroup$185.00$157.4717.48%19.02%
Oct 23, 2024Michael ChernyLeerink Partners$165.00$157.474.78%6.15%
Oct 23, 2024Stephanie DavisBarclays$168.00$157.476.69%8.08%
Oct 23, 2024Eric ColdwellRobert W. Baird$182.00$157.4715.58%17.09%
Oct 22, 2024Paige MeyerCFRA$178.00$157.4613.04%14.51%
Oct 07, 2024David MacDonaldTruist Financial$165.00$150.799.42%6.15%
Jul 29, 2024Ann HynesMizuho Securities$160.00$143.2111.72%2.93%
Jul 24, 2024Eric ColdwellRobert W. Baird$154.00$140.969.25%-0.93%
Jul 15, 2024David MacDonaldTruist Financial$158.00$144.119.64%1.65%
Apr 25, 2024Stephanie DavisBarclays$144.00$137.554.69%-7.36%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024CitigroupBuyBuyhold
Oct 23, 2024Leerink PartnersMarket PerformMarket Performhold
Oct 23, 2024BarclaysEqual-WeightEqual-Weighthold
Aug 27, 2024BarclaysEqual-WeightEqual-Weighthold
Jul 29, 2024Piper SandlerNeutralNeutralhold
Jul 15, 2024Zacks Investment ResearchBuyBuyhold
Jul 10, 2024CitigroupNeutralBuyupgrade
Jun 13, 2024CitigroupNeutralNeutralhold
May 30, 2024UBSBuyBuyhold
Apr 25, 2024BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$7 $8 $9 $10 $11 $12 $13 $14 $15 $16 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.62$15.85$8.10$7.63-----
Avg Forecast$10.80$14.12$9.85$8.71$8.90$9.73$10.51$11.56$12.71
High Forecast$10.32$13.49$9.53$8.68$8.87$9.70$9.86$10.67$12.13
Low Forecast$11.33$14.81$10.03$8.75$8.93$9.77$12.37$12.45$13.00
Surprise %-1.67%12.25%-17.77%-12.40%-----

Revenue Forecast

$9B $10B $10B $11B $12B $13B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.44B$10.79B$9.88B$9.25B-----
Avg Forecast$9.34B$10.74B$9.83B$9.22B$9.83B$10.71B$11.13B$11.68B$12.06B
High Forecast$9.02B$10.37B$9.58B$9.20B$9.81B$10.50B$11.10B$11.49B$11.63B
Low Forecast$9.70B$11.15B$9.97B$9.24B$9.84B$10.84B$11.17B$11.88B$12.27B
Surprise %1.01%0.44%0.54%0.39%-----

Net Income Forecast

$500M $900M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.43B$2.00B$942.00M$854.00M-----
Avg Forecast$1.30B$1.71B$1.31B$850.00M$1.01B$1.10B$1.26B$1.38B$1.44B
High Forecast$1.04B$1.37B$1.04B$680.00M$1.00B$1.10B$1.11B$1.21B$1.37B
Low Forecast$1.56B$2.06B$1.57B$1.02B$1.01B$1.10B$1.40B$1.41B$1.47B
Surprise %9.82%16.48%-27.87%0.47%-----

DGX Forecast FAQ

Is Quest Diagnostics stock a buy?

Quest Diagnostics stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 5 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Quest Diagnostics is a favorable investment for most analysts.

What is Quest Diagnostics's price target?

Quest Diagnostics's price target, set by 12 Wall Street analysts, averages $173.83 over the next 12 months. The price target range spans from $165 at the low end to $185 at the high end, suggesting a potential 11.83% change from the previous close price of $155.44.

How does Quest Diagnostics stock forecast compare to the average forecast of its sector, industry, and investment themes?

Quest Diagnostics stock forecast shows a 11.83% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for Quest Diagnostics over the past three months?

  • January 2025: 5.26% Strong Buy, 47.37% Buy, 47.37% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 5.26% Strong Buy, 42.11% Buy, 52.63% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 4.17% Strong Buy, 33.33% Buy, 58.33% Hold, 4.17% Sell, 0% Strong Sell.

What is Quest Diagnostics’s EPS forecast?

Quest Diagnostics's average annual EPS forecast for its fiscal year ending in December is 8.9 for 2024, a 16.64% increase from the reported $7.63 in 2023. The prediction for 2025 is $9.73, $10.51 for 2026, $11.56 for 2027, and $12.71 for 2028.

What is Quest Diagnostics’s revenue forecast?

Quest Diagnostics's average annual revenue forecast for its fiscal year ending in December is $9.83B for 2024, a 6.24% increase from the reported $9.25B in 2023. The forecast for 2025 is $10.71B, $11.13B for 2026, $11.68B for 2027, and $12.06B for 2028.

What is Quest Diagnostics’s net income forecast?

For its fiscal year ending in December, Quest Diagnostics's average annual net income forecast is $1.01B for 2024, reflecting an 17.76% increase from the reported $854M in 2023. The projection for 2025 is $1.1B, $1.26B for 2026, $1.38B for 2027, and $1.44B for 2028.